The mechanism by which IDH mutation induced preoperative GRE onset was the product of d‐2‐hydroxyglutarate activity in glioma, with IDH mutation potentially increasing neuronal activity by mimicking the activity of glutamate on the NMDA receptor.32 This evidence concerns the gene IDH1 and central nervous system cancer.